IL60095A - Synergistic analgesic pharmaceutical compositions comprising nalbuphine and acetaminophen - Google Patents

Synergistic analgesic pharmaceutical compositions comprising nalbuphine and acetaminophen

Info

Publication number
IL60095A
IL60095A IL60095A IL6009580A IL60095A IL 60095 A IL60095 A IL 60095A IL 60095 A IL60095 A IL 60095A IL 6009580 A IL6009580 A IL 6009580A IL 60095 A IL60095 A IL 60095A
Authority
IL
Israel
Prior art keywords
nalbuphine
acetaminophen
pharmaceutical compositions
analgesic pharmaceutical
synergistic analgesic
Prior art date
Application number
IL60095A
Other languages
English (en)
Other versions
IL60095A0 (en
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of IL60095A0 publication Critical patent/IL60095A0/xx
Publication of IL60095A publication Critical patent/IL60095A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL60095A 1979-05-18 1980-05-16 Synergistic analgesic pharmaceutical compositions comprising nalbuphine and acetaminophen IL60095A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/040,281 US4237140A (en) 1979-05-18 1979-05-18 Analgesic mixture of nalbuphine and acetaminophen

Publications (2)

Publication Number Publication Date
IL60095A0 IL60095A0 (en) 1980-07-31
IL60095A true IL60095A (en) 1982-12-31

Family

ID=21910135

Family Applications (1)

Application Number Title Priority Date Filing Date
IL60095A IL60095A (en) 1979-05-18 1980-05-16 Synergistic analgesic pharmaceutical compositions comprising nalbuphine and acetaminophen

Country Status (12)

Country Link
US (1) US4237140A (cg-RX-API-DMAC10.html)
EP (1) EP0019282B1 (cg-RX-API-DMAC10.html)
JP (1) JPS55154917A (cg-RX-API-DMAC10.html)
AU (1) AU529764B2 (cg-RX-API-DMAC10.html)
CA (1) CA1139671A (cg-RX-API-DMAC10.html)
DE (1) DE3061597D1 (cg-RX-API-DMAC10.html)
HU (1) HU178867B (cg-RX-API-DMAC10.html)
IE (1) IE49988B1 (cg-RX-API-DMAC10.html)
IL (1) IL60095A (cg-RX-API-DMAC10.html)
NZ (1) NZ193695A (cg-RX-API-DMAC10.html)
PH (1) PH15265A (cg-RX-API-DMAC10.html)
ZA (1) ZA802916B (cg-RX-API-DMAC10.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
US4366159A (en) * 1981-09-08 1982-12-28 Michael Richard Magruder Nalbuphine-narcotic analgesic composition and method of producing analgesia
US4407805A (en) * 1982-06-30 1983-10-04 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and zomepirac
US4404209A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and sulindac
US4404210A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and ibuprofen
US4407804A (en) * 1982-06-30 1983-10-04 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and indomethacin
US4404211A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and flurbiprofen
US4404208A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and tiflamizole
AU565634B2 (en) * 1982-06-30 1987-09-24 E.I. Du Pont De Nemours And Company Synergistic compositions of nalbuphine and non-narcotic analgesic compounds
US4402962A (en) * 1982-06-30 1983-09-06 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and 4,5-bis(4-methoxyphenyl)-2-(trifluoromethylsulfonyl)-1H-imidazole
US4656177A (en) * 1982-07-22 1987-04-07 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
AT389226B (de) * 1982-07-22 1989-11-10 Richardson Vicks Inc Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung
US4777174A (en) * 1982-07-22 1988-10-11 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4600579A (en) * 1983-06-07 1986-07-15 Mallinckrodt, Inc. N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same
US4722928A (en) * 1985-12-02 1988-02-02 E. I. Du Pont De Nemours And Company N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans having improved oral bioavailability, pharmaceutical compositions, and processes
DK0566709T5 (da) 1991-09-06 2009-05-18 Ortho Mcneil Janssen Pharm Præparat indeholdende et tramadolmateriale og acetaminophen og anvendelse deraf
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
EP1685839B8 (en) 1997-12-22 2013-06-26 Euro-Celtique S.A. Pharmaceutical oral dosage form comprising a combination of an opioid agonist and opioid antagonist
GEP20053614B (en) * 2000-02-08 2005-09-26 Euro Celtique Sa Compositions for Oral Administration Containing Opioid Agonist
CA2446550C (en) 2001-05-11 2012-03-06 Endo Pharmaceuticals, Inc. Abuse-resistant controlled-release opioid dosage form
JP4256259B2 (ja) 2001-07-18 2009-04-22 ユーロ−セルティーク エス.エイ. オキシコドン及びナロキソンの医薬配合物
PT1414451E (pt) 2001-08-06 2009-07-31 Euro Celtique Sa Formulações agonistas de opióides com antagonista libertável e sequestrado
US20030157168A1 (en) 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
ES2627298T3 (es) 2002-04-05 2017-07-27 Mundipharma Pharmaceuticals S.L. Preparación farmacéutica que contiene oxicodona y naloxona
ES2677769T3 (es) 2002-09-20 2018-08-06 Alpharma Pharmaceuticals Llc Subunidad secuestrante y composiciones y procedimientos relacionados
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
HUE053838T2 (hu) 2005-08-24 2021-07-28 Endo Pharmaceuticals Inc Nyújtott felszabadulású nabulfin-készítmények
US8394812B2 (en) 2005-08-24 2013-03-12 Penwest Pharmaceuticals Co. Sustained release formulations of nalbuphine
RU2445077C2 (ru) 2006-06-19 2012-03-20 АЛФАРМА, Инк. Фармацевтические композиции
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
RS58240B1 (sr) 2009-03-10 2019-03-29 Euro Celtique Sa Farmaceutske kombinacije sa trenutnim oslobađanjem koje obuhvataju oksikodon i nalokson
WO2015011189A1 (en) 2013-07-23 2015-01-29 Euro-Celtique S.A. A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
SI3639828T1 (sl) 2013-12-24 2022-04-29 Virginia Commonwealth University Uporaba oksigeniranih holesterol sulfatov (OCS) za zdravljenje akutne odpovedi jeter
JOP20190094A1 (ar) * 2016-10-27 2019-04-25 Broad Inst Inc مركبات 1، 2، 4-تريازولون تحمل ثلاثة بدائل عند المواقع 2، 4، 5 مفيدة كمثبطات لديهيدروجيناز ثنائي هيدرو أوروتات (dhodh)
WO2019070917A1 (en) * 2017-10-03 2019-04-11 The Schepens Eye Research Institute, Inc. COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE DEGENERATION OF RETINAL PIGMENT EPITHELIUM AND METHODS USING SAME
CN113164469A (zh) * 2018-09-03 2021-07-23 雅各生技有限公司 双那布扶林己二酸酯和乙酰胺酚的药物制剂及治疗疼痛的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL26896A (en) * 1966-01-19 1970-11-30 Endo Lab 14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones
US4029798A (en) * 1975-06-02 1977-06-14 Sumitomo Chemical Company, Limited Analgetic composition
JPS5946205B2 (ja) * 1976-01-01 1984-11-10 科研製薬株式会社 ベンゾイル誘導体を有効成分とする消炎鎮痛剤

Also Published As

Publication number Publication date
DE3061597D1 (en) 1983-02-17
EP0019282A1 (en) 1980-11-26
CA1139671A (en) 1983-01-18
ZA802916B (en) 1981-12-30
JPH0144684B2 (cg-RX-API-DMAC10.html) 1989-09-29
AU529764B2 (en) 1983-06-16
AU5835180A (en) 1980-11-20
IE49988B1 (en) 1986-01-22
JPS55154917A (en) 1980-12-02
IL60095A0 (en) 1980-07-31
PH15265A (en) 1982-11-02
US4237140A (en) 1980-12-02
IE801019L (en) 1980-11-18
NZ193695A (en) 1984-05-31
HU178867B (en) 1982-07-28
EP0019282B1 (en) 1983-01-12

Similar Documents

Publication Publication Date Title
IL60095A (en) Synergistic analgesic pharmaceutical compositions comprising nalbuphine and acetaminophen
GB2103591B (en) Pharmaceutical compositions and process
DE3372705D1 (en) Pharmaceutical composition and its use
NZ194432A (en) Lipophilic muramyl-peptides and pharmaceutical compositions
PT76147A (en) Process for the preparation of pyrazolooxazines pyrazolothiazines and pyrazoloquinolines with a lipoxygenase inhibiting effect and their use for the preparation of pharmaceutical compositions having a lipoxygenase inhibiting effect
NZ194961A (en) Enkephalin analogues and pharmaceutical compositions
NZ194584A (en) -lactam antibiotics and pharmaceutical compositions
NZ210105A (en) Oxazolidine derivatives and pharmaceutical compositions
IL60550A (en) Pharmaceutical compositions comprising aryl-pyrazolineamine derivatives and certain novel such compounds
PH16443A (en) Substituted tetraazetricyclic compounds and their pharmaceutical compositions
IL61700A (en) Analgesic tetrapeptides,their preparation and pharmaceutical compositions comprising them
IL61703A (en) Analgesic pentapeptides,their preparation and pharmaceutical compositions comprising them
IL61117A0 (en) Acetoxymethyl-penem compounds and pharmaceutical compositions containing them
GB2047534B (en) Analgesic and myotonolytic compositions
IL60376A (en) 3-diphenylmethyleneazetidines and pharmaceutical compositions containing them
NZ194784A (en) 7 -aminothiadizolylacetylamino-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions
IL61701A (en) Analgesic pentapeptides,their preparation and pharmaceutical compositions comprising them
GB2050833B (en) Pharmaceutical compositions and process for the preparation thereof
IL69058A0 (en) Synergistic pharmaceutical analgesic compositions
PH16220A (en) Pyrro-lidine derivatives and pharmaceutical compositions thereof
IL59177A0 (en) Spiro-quinolylhydantoins and pharmaceutical compositions containing them
NZ203649A (en) 2-beta-d-ribofuranosylselenazole-4-carboxamide derivatives and pharmaceutical compositions
NZ205732A (en) Thiatriazine derivatives and pharmaceutical compositions
PH19604A (en) Isoquinoline derivatives and pharmaceutical compositions containing the same
IL60695A (en) Hexahydro-trans-pyridoindole-alkanamine derivatives and pharmaceutical compositions containing them